2 studies found for:    10647931 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors
Conditions: Sarcoma;   Neuroblastoma;   Wilms Tumor;   Osteosarcoma;   Brain Tumor
Intervention: Drug: Pazopanib (GW786034)
2 Withdrawn 18F-CP18 Imaging Studies for Cancer Treatment With Birinapant
Conditions: Ovarian Neoplasms;   Ovarian Cancer;   Fallopian Tube Neoplasms;   Fallopian Tube Cancer
Interventions: Drug: [18F]-CP18;   Procedure: PET/ CT

Indicates status has not been verified in more than two years